148 related articles for article (PubMed ID: 37256198)
1. DCvax: A promising advancement in oncology for the treatment of glioblastoma.
Fareed A; Rohail S; Adnan A; Khan AM
Rare Tumors; 2023; 15():20363613231179541. PubMed ID: 37256198
[No Abstract] [Full Text] [Related]
2. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
de Godoy LL; Chawla S; Brem S; Wang S; O'Rourke DM; Nasrallah MP; Desai A; Loevner LA; Liau LM; Mohan S
J Neurooncol; 2023 May; 163(1):173-183. PubMed ID: 37129737
[TBL] [Abstract][Full Text] [Related]
3. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Liau LM; Ashkan K; Tran DD; Campian JL; Trusheim JE; Cobbs CS; Heth JA; Salacz M; Taylor S; D'Andre SD; Iwamoto FM; Dropcho EJ; Moshel YA; Walter KA; Pillainayagam CP; Aiken R; Chaudhary R; Goldlust SA; Bota DA; Duic P; Grewal J; Elinzano H; Toms SA; Lillehei KO; Mikkelsen T; Walbert T; Abram SR; Brenner AJ; Brem S; Ewend MG; Khagi S; Portnow J; Kim LJ; Loudon WG; Thompson RC; Avigan DE; Fink KL; Geoffroy FJ; Lindhorst S; Lutzky J; Sloan AE; Schackert G; Krex D; Meisel HJ; Wu J; Davis RP; Duma C; Etame AB; Mathieu D; Kesari S; Piccioni D; Westphal M; Baskin DS; New PZ; Lacroix M; May SA; Pluard TJ; Tse V; Green RM; Villano JL; Pearlman M; Petrecca K; Schulder M; Taylor LP; Maida AE; Prins RM; Cloughesy TF; Mulholland P; Bosch ML
J Transl Med; 2018 May; 16(1):142. PubMed ID: 29843811
[TBL] [Abstract][Full Text] [Related]
4. DCVax-Brain and DC vaccines in the treatment of GBM.
Wheeler CJ; Black KL
Expert Opin Investig Drugs; 2009 Apr; 18(4):509-19. PubMed ID: 19335279
[TBL] [Abstract][Full Text] [Related]
5. Technology evaluation: DCVax, Northwest Biotherapeutics.
Knutson KL
Curr Opin Mol Ther; 2002 Aug; 4(4):403-7. PubMed ID: 12222879
[TBL] [Abstract][Full Text] [Related]
6. DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open.
Gatto L; Di Nunno V; Tosoni A; Bartolini S; Ranieri L; Franceschi E
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370860
[TBL] [Abstract][Full Text] [Related]
7. DCVax®-L--developed by Northwest Biotherapeutics.
Polyzoidis S; Ashkan K
Hum Vaccin Immunother; 2014; 10(11):3139-45. PubMed ID: 25483653
[TBL] [Abstract][Full Text] [Related]
8. A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer.
Fishman M
Expert Opin Biol Ther; 2009 Dec; 9(12):1565-75. PubMed ID: 19916735
[TBL] [Abstract][Full Text] [Related]
9. Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?
Olivier T; Migliorini D
Rev Neurol (Paris); 2023 Jun; 179(5):502-505. PubMed ID: 37012085
[TBL] [Abstract][Full Text] [Related]
10. First results on the DCVax phase III trial: raising more questions than providing answers.
Wick W; van den Bent MJ
Neuro Oncol; 2018 Sep; 20(10):1283-1284. PubMed ID: 30137551
[No Abstract] [Full Text] [Related]
11. Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
Van Gool SW; Makalowski J; Kampers LFC; Van de Vliet P; Sprenger T; Schirrmacher V; Stücker W
Transl Cancer Res; 2023 Aug; 12(8):2224-2228. PubMed ID: 37701100
[No Abstract] [Full Text] [Related]
12. The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma.
Neth BJ; Webb MJ; Parney IF; Sener UT
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111620
[TBL] [Abstract][Full Text] [Related]
13. Guidelines, "minimal requirements" and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working party.
;
Crit Rev Oncol Hematol; 2016 Feb; 98():189-99. PubMed ID: 26626226
[TBL] [Abstract][Full Text] [Related]
14. Role of Molecular Targeted Therapeutic Drugs in Treatment of Glioblastoma: A Review Article.
Singh H
Glob Med Genet; 2023 Jun; 10(2):42-47. PubMed ID: 37077370
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges.
Luzzi S; Giotta Lucifero A; Brambilla I; Magistrali M; Mosconi M; Savasta S; Foiadelli T
Acta Biomed; 2020 Jun; 91(7-S):18-31. PubMed ID: 32608373
[TBL] [Abstract][Full Text] [Related]
16. Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery.
Carlson BL; Pokorny JL; Schroeder MA; Sarkaria JN
Curr Protoc Pharmacol; 2011 Mar; Chapter 14(14):Unit 14.16. PubMed ID: 21743824
[TBL] [Abstract][Full Text] [Related]
17. Obstacles to Glioblastoma Treatment Two Decades after Temozolomide.
Cruz JVR; Batista C; Afonso BH; Alexandre-Moreira MS; Dubois LG; Pontes B; Moura Neto V; Mendes FA
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804976
[TBL] [Abstract][Full Text] [Related]
18. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Chuntova P; Chow F; Watchmaker PB; Galvez M; Heimberger AB; Newell EW; Diaz A; DePinho RA; Li MO; Wherry EJ; Mitchell D; Terabe M; Wainwright DA; Berzofsky JA; Herold-Mende C; Heath JR; Lim M; Margolin KA; Chiocca EA; Kasahara N; Ellingson BM; Brown CE; Chen Y; Fecci PE; Reardon DA; Dunn GP; Liau LM; Costello JF; Wick W; Cloughesy T; Timmer WC; Wen PY; Prins RM; Platten M; Okada H
Neuro Oncol; 2021 Mar; 23(3):356-375. PubMed ID: 33367885
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology.
de Almeida Magalhães T; de Sousa GR; Alencastro Veiga Cruzeiro G; Tone LG; Valera ET; Borges KS
J Mol Med (Berl); 2020 Apr; 98(4):495-512. PubMed ID: 32219470
[TBL] [Abstract][Full Text] [Related]
20. Radiomics for precision medicine in glioblastoma.
Aftab K; Aamir FB; Mallick S; Mubarak F; Pope WB; Mikkelsen T; Rock JP; Enam SA
J Neurooncol; 2022 Jan; 156(2):217-231. PubMed ID: 35020109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
